Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues
Vanda Pharmaceuticals Inc. (VNDA) had Profit Margin of -102.02% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$216.10M |
|
$-220.47M |
|
$13.04M |
|
$203.06M |
|
$367.27M |
|
$-151.17M |
|
$12.52M |
|
$-138.65M |
|
$-138.65M |
|
$-220.47M |
|
$-220.47M |
|
$-220.47M |
|
$-220.47M |
|
$-151.17M |
|
$-141.30M |
|
58.93M |
|
58.93M |
|
$-3.74 |
|
$-3.74 |
|
| Balance Sheet Financials | |
$347.26M |
|
$2.25M |
|
$141.69M |
|
$488.95M |
|
$145.16M |
|
$4.08M |
|
$16.60M |
|
$161.76M |
|
$327.19M |
|
$210.10M |
|
$327.19M |
|
59.10M |
|
| Cash Flow Statement Financials | |
$-109.44M |
|
$94.86M |
|
$-2.91M |
|
$102.78M |
|
$85.32M |
|
$-17.46M |
|
$9.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.39 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
93.96% |
|
-69.95% |
|
-69.95% |
|
-65.39% |
|
-64.16% |
|
|
Profit Margin |
-102.02% |
$-110.44M |
|
-- |
|
-- |
|
-- |
|
0.44 |
|
7.04 |
|
3.96 |
|
92.18 |
|
-67.38% |
|
-104.94% |
|
-45.09% |
|
-66.56% |
|
$5.54 |
|
$-1.87 |
|
$-1.86 |
|